Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

August 18, 2023

Study Completion Date

August 18, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

Asunercept

Asunercept (APG101) will be administered once per week as an i.v. infusion

OTHER

Placebo

Placebo will be administered once per week as an i.v. infusion

Trial Locations (39)

Unknown

Univeritätsklinik für Innere Medizin I, Vienna

CHU Amiens - Site Sud, Centre de Recherche Clinique, Amiens

Dubois Hospital, Service de médecine intensive Réanimation, Brive-la-Gaillarde

CHU de Limoges - Hopital Dupuytren, Limoges

Georges Pompidou European Hospital, Paris

"Ltd Hospital Service", Kutaisi

"Ltd Academician Nikoloz Kipshidze Central University Clinic", Tbilisi

"Ltd Academician Vakhtang Bochorishvili Clinic", Tbilisi

"Ltd TSMU and Ingorokva High Medical Technology University Clinic", Tbilisi

Uniklinik Köln - Klinik I für Innere Medizin, Cologne

Universitätsklinikum Heidelberg, Heidelberg

King George Hospital, Visakhapatnam

Citizen Hospital, Bangalore

JSS Hospital, Mysore

Spandan Hospital, Pune

Govtl. Medical College and Hospital Aurangabad, Aurangabad

PCMC PGI Yashwantrao Chavan Memorial Hospital, Pune

Ashirwad Hospital and Research Centre, Ulhasnagar

Atharva Multispecialty Hospital and Research Center, Lucknow

Victoria Hospital, BMCRI Bangalore Medical College & Research Institute, Bangalore

KLES Dr. Prabhakar Kore Hospital & Medical Research Center, Nehru Nagar

Unity Hospital, Sūrat

ASST Santi Paolo e Carlo, Milan

ASST Fatebenefratelli Sacco, Milan

Azienda Ospedaliera Universitaria L. Vanvitelli, Napoli

Azienda Ospedaliere Universitaria Federico I, Napoli

ZOZ w Boleslawcu, Bolesławiec

Nicolaus Copernicus Hospital, Koszalin

Regional Specialist Hospital, Wroclaw

Global Clinical Trials, Pretoria

Lakeview Hospital, Benoni

Synapta Clinical Research, 704 Durban Medical Centre, Durban

Helen Joseph Hospital, Johannesburg

FCRN Clinical Trials Centre, Three Rivers

Hospital General Universitario de Alicante Dr. Balmis, Alicante

Hospital del Mar, Barcelona

Complejo Asistencial Universitario de Salamanca, Salamanca

Hospital Universitario Río Hortega, Valladolid

Complejo Hospitalario Universitario de Vigo - Hospital Álvaro Cunqueiro, Vigo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Apogenix GmbH

INDUSTRY